Also, protein nanoparticles constructed via the albumin–GP60 interaction demonstrated a strong ability to overcome cancer drug resistance, and it was expected to be further used in clinical practice (Hassanin and Elzoghby, 2020). The gene discussed is ALB; the disease is cancer.